Daniel A Hutta

Title: The Innovative Contributions of Daniel A. Hutta

Introduction

Daniel A. Hutta is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific receptors and kinases. With a total of 3 patents to his name, Hutta's work is instrumental in advancing medical treatments.

Latest Patents

Hutta's latest patents include groundbreaking inventions that address critical medical needs. One of his notable inventions is related to hetero isonipecotic modulators of the vanilloid VR1 receptor. This invention focuses on vanilloid receptor VR1 ligands, specifically hetero isonipecotic amides that serve as potent modulators of VR1. These compounds are useful for the treatment and prevention of various disease conditions in mammals. Another significant patent involves 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase. This invention provides selective and potent protein tyrosine kinase inhibitors, addressing the need for effective treatments in this area.

Career Highlights

Daniel A. Hutta is currently associated with Janssen Pharmaceutica NV, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective therapeutic solutions that can improve patient outcomes.

Collaborations

Hutta has collaborated with esteemed colleagues, including Micheal D. Gaul and Bao-Ping Zhao. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Daniel A. Hutta's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.